Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans

Clinical Endocrinology

Volumn 71, Issue 2, 2009, Pages 202-207

  Liu, Sheng Wen ^b   Qiao, Shu Bin ^a,b   Yuan, Jian Song ^b   Liu, Dong Qin ^b  

^a Chinese Academy of Medical Sciences ^*  (China)

^b FUWAI HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INSULIN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; HUMAN; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

ACUTE CORONARY SYNDROME; AGED; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

EID: 67650327064     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03453.x     Document Type: Article

References (30)

1. Eckel, R.H., York, D.A., Rossner, S. et al. American heart association (2004) Prevention conference VII: obesity, a worldwide epidemic related to heart disease and stroke: executive summary. Circulation, 110, 2968 2975. (Pubitemid 39473624)
2. Lakka, H.M., Laaksonen, D.E., Lakka, T.A. et al. (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. Journal of the American Medical Association, 288, 2709 2716. (Pubitemid 35403784)
3. Spiegelman, B.M., Choy, L., Hotamisligil, G.S. et al. (1993) Regulation of adipocyte gene expression in differentiation and syndromes of obesity/diabetes. Journal of Biological Chemistry, 268, 6823 6826.
4. Maeda, K., Okubo, K., Shimomura, I. et al. (1997) Analysis of expression profile of genes in the human adipose tissue. Gene, 190, 227 235. (Pubitemid 27220127)
5. Tedgui, A. Mallat, Z. (2006) Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiological Reviews, 86, 515 581.
6. Wu, Z.H. Zhao, S.P. (2006) Adipocyte: a potential target for the treatment of atherosclerosis. Medical Hypotheses, 67, 82 86.
7. Fukuhara, A., Matsuda, M., Nishizawa, M. et al. (2005) Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science, 307, 426 430. (Pubitemid 40139988)
8. Samal, B., Sun, Y., Stearns, G. et al. (1994) Cloning and characterization of the cDNA encoding a novel human pre-B-cell colonyenhancing factor. Molecular and Cellular Biology, 14, 1431 1437.
9. McGlothlin, J.R., Gao, L., Lavoie, T. et al. (2005) Molecular cloning and characterization of canine pre-B-cell colony-enhancing factor. Biochemical Genetics, 43, 127 141. (Pubitemid 40543710)
10. Kaser, A., Ludwiczek, O., Holzmann, S. et al. (2007) Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. The Journal of Immunology, 178, 1748 1758. (Pubitemid 46154646)
11. Dahl, T.B., Yndestad, A., Skjelland, M. et al. (2007) Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization. Circulation, 115, 972 980. (Pubitemid 46328290)
12. Takebayashi, K., Suetsugu, M., Wakabayashi, S. et al. (2007) Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus. Metabolism, 56, 451 458. (Pubitemid 46427838)
13. Fukuhara, A., Matsuda, M., Nishizawa, M. et al. (2007) Retraction. Science, 318, 565.
14. Levey, A.S., Coresh, J., Balk, E. et al. (2003) National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Annals of Internal Medicine, 139, 137 147.
15. The Expert Committee (1997) Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 20, 1183 1197.
16. Matthews, D.R., Hosker, J.P., Rudenski, A.S. et al. (1985) Homeostasis model assessment: insulin resistance and B-cell function from plasma glucose and insulin concentrations in man. Diabetologia, 28, 412 419. (Pubitemid 15018832)
17. Ognjanovic, S., Bao, S., Yamamoto, S.Y. et al. (2001) Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes. Journal of Molecular Endocrinology, 26, 107 117. (Pubitemid 32266186)
18. Jia, S.H., Li, Y., Parodo, J. et al. (2004) Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. Journal of Clinical Investigation, 113, 1318 1327. (Pubitemid 39069931)
19. Koczan, D., Guthke, R., Thiesen, H.J. et al. (2005) Gene expression profiling of peripheral blood mononuclear leukocytes from psoriasis patients identifies new immune regulatory molecules. European Journal of Dermatology, 15, 251 257. (Pubitemid 41020851)
20. Nowell, M.A., Richards, P.J., Fielding, C.A. et al. (2006) Regulation of pre-B cell colony-enhancing factor by e STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis. Arthritis and Rheumatism, 54, 2084 2095. (Pubitemid 44051064)
21. Adya, R., Tan, B.K., Punn, A. et al. (2008) Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis. Cardiovascular Research, 78, 356 365. (Pubitemid 351556097)
22. van der Wal, A.C. Becker, A.E. (1999) Atherosclerotic plaque rupture-pathologic basis of plaque stability and instability. Cardiovascular Research, 41, 334 344. (Pubitemid 29087330)
23. Charo, I.F. Taubman, M.B. (2004) Chemokines in the pathogenesis of vascular disease. Circulation Research, 95, 858 866. (Pubitemid 39435000)
24. de Lemos, J.A., Morrow, D.A., Blazing, M.A. et al. (2007) Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial. Journal of the American College of Cardiology, 50, 2117 2124. (Pubitemid 350117348)
25. Yudkin, J.S., Kumari, M., Humphries, S.E. et al. (2000) Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis, 148, 209 214. (Pubitemid 30064452)
26. Hartford, M., Wiklund, O., Mattsson Hultén, L. et al. (2007) C-reactive protein, interleukin-6, secretory phospholipase A2 group IIA and intercellular adhesion molecule-1 in the prediction of late outcome events after acute coronary syndromes. Journal of Internal Medicine, 262, 526 536. (Pubitemid 47620509)
27. Matsumori, A., Furukawa, Y., Hashimoto, T. et al. (1997) Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction. Journal of Molecular and Cellular Cardiology, 29, 419 423. (Pubitemid 27129164)
28. Pagano, C., Pilon, C., Olivieri, M. et al. (2006) Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans. Journal of Clinical Endocrinology and Metabolism, 91, 3165 3170. (Pubitemid 44271773)
29. Oki, K., Yamane, K., Kamei, N. et al. (2007) Circulating visfatin level is correlated with inflammation, but not with insulin resistance. Clinical Endocrinology, 67, 796 800. (Pubitemid 47628470)
30. Kowalska, I., Straczkowski, M., Nikolajuk, A. et al. (2007) Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome. Human Reproduction, 22, 1824 1829. (Pubitemid 47062747)